Clinical White Papers and Case Studies

  1. GxP Inventory Delivers Real-Time Visibility, Operational Efficiency 11/17/2025

    Modernize your clinical supply chain to streamline global trial operations, ensure regulatory compliance, and deliver investigational therapies to patients efficiently and reliably.

  2. Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting 11/17/2025

    Streamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.

  3. Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer 11/17/2025

    Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.

  4. Rescuing Data Integrity: A Swift Transition And Quality Transformation 11/14/2025

    Uncover how this collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.

  5. Quantitative ROI With DCTs 11/13/2025

    Through dedicated staffing, operational oversight, and collaboration with site teams, see how we were able to transform a struggling cardiology study into a revitalized recruitment effort.

  6. The True ROI Of Decentralized Clinical Trials 11/13/2025

    Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.

  7. Retention Begins With Recruiting The Right-Fit Patients 11/13/2025

    Recruiting the right patients into a clinical trial is only half the battle. To combat attrition, sponsors must also institute measures that ensure patients remain comfortable and confident throughout the trial.

  8. 4 New Approvals In Q3 Across Gene, Cell, RNA Therapies 11/13/2025

    Q3 2025 brought notable progress across the gene, cell, and RNA therapy landscape, marked by four new global approvals. While regulatory progress continued, clinical development activity slowed.

  9. Addressing A Global Health Priority In Australia And New Zealand 11/7/2025

    For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.

  10. Therapeutic Radiopharmaceuticals: Clinical Research, CRO Enablers (2025) 11/7/2025

    Accelerate the future of precision oncology by driving innovation, optimizing clinical development, and expanding access to targeted therapies that transform patient outcomes.